Randomized trial explores enhancing clinical decision support through explainable AI, suggesting improved transparency.
As the healthcare industry transitions toward the Healthcare 5.0 paradigm [10], deep learning models have demonstrated superior predictive performance across critical clinical domains, including oncology [5], cardiology [1, 7], neurology [11, 15], and behavioral health [6]. However, the clinical adoption of these high-performing systems remains obstructed by the
No takes yet. Share an insight, caveat, or question.
Raghavendra et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: